Circulating Tumor Cells (CTC) Market Report by Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, CTC Analysis), Application (Clinical/Liquid Biopsy, Research), Product (Kits and Reagents, Blood Collection Tubes, Devices and Systems), Specimen (Blood, Bone Marrow, Other Body Fluids), End User (Hospital and Clinics, Research and Academic Institutes, Diagnostic Centres), and Region 2025-2033

April 2025 | 137 pages | ID: C574ABCEC950EN
IMARC Group

US$ 2,999.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global circulating tumor cells (CTC) market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.46% during 2025-2033. The rising prevalence of genetic disorders, owing to lifestyle changes, is propelling the market.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the circulating tumor cells (CTC) market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the technology, application, product, specimen, and end user.

Breakup by Technology:
  • CTC Detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis
Breakup by Application:
  • Clinical/Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
  • Research
  • Cancer Stem Cell and Tumorigenesis Research
  • Drug/Therapy Development
Breakup by Product:
  • Kits and Reagents
  • Blood Collection Tubes
  • Devices and Systems
Breakup by Specimen:
  • Blood
  • Bone Marrow
  • Other Body Fluids
Breakup by End User:
  • Hospital and Clinics
  • Research and Academic Institutes
  • Diagnostic Centres
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Key Questions Answered in This Report

1.What was the size of the global Circulating Tumor Cells (CTC) market in 2024?

2.What is the expected growth rate of the global Circulating Tumor Cells (CTC) market during 2025-2033?

3.What are the key factors driving the global Circulating Tumor Cells (CTC) market?

4.What has been the impact of COVID-19 on the global Circulating Tumor Cells (CTC) market?

5.What is the breakup of the global circulating tumor cells (CTC) market based on technology?

6.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the application?

7.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the product?

8. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the specimen?

9.What are the key regions in the global Circulating Tumor Cells (CTC) market?

10.Who are the key players/companies in the global Circulating Tumor Cells (CTC) market?
1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 INTRODUCTION

4.1 Overview
4.2 Key Industry Trends

5 GLOBAL CIRCULATING TUMOR CELLS (CTC) MARKET

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 MARKET BREAKUP BY TECHNOLOGY

6.1 CTC Detection and Enrichment Method
  6.1.1 Market Trends
  6.1.2 Market Forecast
6.2 CTC Direct Detection Methods
  6.2.1 Market Trends
  6.2.2 Market Forecast
6.3 CTC Analysis
  6.3.1 Market Trends
  6.3.2 Market Forecast

7 MARKET BREAKUP BY APPLICATION

7.1 Clinical/Liquid Biopsy
  7.1.1 Market Trends
  7.1.2 Key Segments
    7.1.2.1 Risk Assessment
    7.1.2.2 Screening and Monitoring
  7.1.3 Market Forecast
7.2 Research
  7.2.1 Market Trends
  7.2.2 Key Segments
    7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
    7.2.2.2 Drug/Therapy Development
  7.2.3 Market Forecast

8 MARKET BREAKUP BY PRODUCT

8.1 Kits and Reagents
  8.1.1 Market Trends
  8.1.2 Market Forecast
8.2 Blood Collection Tubes
  8.2.1 Market Trends
  8.2.2 Market Forecast
8.3 Devices or Systems
  8.3.1 Market Trends
  8.3.2 Market Forecast

9 MARKET BREAKUP BY SPECIMEN

9.1 Blood
  9.1.1 Market Trends
  9.1.2 Market Forecast
9.2 Bone Marrow
  9.2.1 Market Trends
  9.2.2 Market Forecast
9.3 Other Body Fluids
  9.3.1 Market Trends
  9.3.2 Market Forecast

10 MARKET BREAKUP BY END USER

10.1 Hospital and Clinics
  10.1.1 Market Trends
  10.1.2 Market Forecast
10.2 Research and Academic Institutes
  10.2.1 Market Trends
  10.2.2 Market Forecast
10.3 Diagnostic Centres
  10.3.1 Market Trends
  10.3.2 Market Forecast

11 MARKET BREAKUP BY REGION

11.1 North America
  11.1.1 United States
    11.1.1.1 Market Trends
    11.1.1.2 Market Forecast
  11.1.2 Canada
    11.1.2.1 Market Trends
    11.1.2.2 Market Forecast
11.2 Asia-Pacific
  11.2.1 China
    11.2.1.1 Market Trends
    11.2.1.2 Market Forecast
  11.2.2 Japan
    11.2.2.1 Market Trends
    11.2.2.2 Market Forecast
  11.2.3 India
    11.2.3.1 Market Trends
    11.2.3.2 Market Forecast
  11.2.4 South Korea
    11.2.4.1 Market Trends
    11.2.4.2 Market Forecast
  11.2.5 Australia
    11.2.5.1 Market Trends
    11.2.5.2 Market Forecast
  11.2.6 Indonesia
    11.2.6.1 Market Trends
    11.2.6.2 Market Forecast
  11.2.7 Others
    11.2.7.1 Market Trends
    11.2.7.2 Market Forecast
11.3 Europe
  11.3.1 Germany
    11.3.1.1 Market Trends
    11.3.1.2 Market Forecast
  11.3.2 France
    11.3.2.1 Market Trends
    11.3.2.2 Market Forecast
  11.3.3 United Kingdom
    11.3.3.1 Market Trends
    11.3.3.2 Market Forecast
  11.3.4 Italy
    11.3.4.1 Market Trends
    11.3.4.2 Market Forecast
  11.3.5 Spain
    11.3.5.1 Market Trends
    11.3.5.2 Market Forecast
  11.3.6 Russia
    11.3.6.1 Market Trends
    11.3.6.2 Market Forecast
  11.3.7 Others
    11.3.7.1 Market Trends
    11.3.7.2 Market Forecast
11.4 Latin America
  11.4.1 Brazil
    11.4.1.1 Market Trends
    11.4.1.2 Market Forecast
  11.4.2 Mexico
    11.4.2.1 Market Trends
    11.4.2.2 Market Forecast
  11.4.3 Others
    11.4.3.1 Market Trends
    11.4.3.2 Market Forecast
11.5 Middle East and Africa
  11.5.1 Market Trends
  11.5.2 Market Breakup by Country
  11.5.3 Market Forecast

12 SWOT ANALYSIS

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 VALUE CHAIN ANALYSIS

14 PORTERS FIVE FORCES ANALYSIS

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 PRICE ANALYSIS

16 COMPETITIVE LANDSCAPE

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
  16.3.1 BioFluidica Inc
    16.3.1.1 Company Overview
    16.3.1.2 Product Portfolio
  16.3.2 Creatv MicroTech Inc.
    16.3.2.1 Company Overview
    16.3.2.2 Product Portfolio
  16.3.3 CytoLumina Technologies Corp.
    16.3.3.1 Company Overview
    16.3.3.2 Product Portfolio
  16.3.4 Fluxion Biosciences Inc.
    16.3.4.1 Company Overview
    16.3.4.2 Product Portfolio
  16.3.5 Greiner Bio-One International GmbH
    16.3.5.1 Company Overview
    16.3.5.2 Product Portfolio
  16.3.6 Ikonisys Inc
    16.3.6.1 Company Overview
    16.3.6.2 Product Portfolio
  16.3.7 Menarini Silicon Biosystems
    16.3.7.1 Company Overview
    16.3.7.2 Product Portfolio
  16.3.8 Miltenyi Biotec
    16.3.8.1 Company Overview
    16.3.8.2 Product Portfolio
  16.3.9 Qiagen N.V
    16.3.9.1 Company Overview
    16.3.9.2 Product Portfolio
  16.3.10 Rarecells Diagnostics
    16.3.10.1 Company Overview
    16.3.10.2 Product Portfolio
  16.3.11 Stemcell Technologies
    16.3.11.1 Company Overview
    16.3.11.2 Product Portfolio


LIST OF TABLES

Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million ?????????????????????USD), 2025-2033
Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million ?????????????????????USD), 2025-2033
Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million ?????????????????????USD), 2025-2033
Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million ?????????????????????USD), 2025-2033
Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million ?????????????????????USD), 2025-2033
Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million ?????????????????????USD), 2025-2033
Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
Table 9: Global: Circulating Tumor Cells Market: Key Players

LIST OF FIGURES

Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2024
Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2024
Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2024
Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2024
Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2024
Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2024
Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million ?????????????????????USD), 2019 & 2024
Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2024
Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million ?????????????????????USD), 2025-2033
Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis


More Publications